Articles From: Vitesse Reports Fourth Quarter and Fiscal Year 2014 Results to VIVUS Reports Third Quarter 2014 Financial Results


Vitesse Semiconductor Corporation (Nasdaq: VTSS), a leading provider of IC solutions to advance “Ethernet Everywhere” in Carrier , Enterprise and Internet of Things (IoT) networks , reported its financial results for the fourth quarter and fiscal year 2014, ended September 30, 2014.
Sign-up for Vitesse Reports Fourth Quarter and Fiscal Year 2014 Results investment picks
Vitesse Semiconductor Corporation (Nasdaq: VTSS), a leading provider of IC solutions to advance “Ethernet Everywhere” in Carrier , Enterprise and Internet of Things (IoT) networks , will conduct a conference call on Thursday, December 4, 2014, at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to report financial results for the fourth quarter and fiscal year 2014.
Sign-up for Vitesse Schedules Fourth Quarter and Fiscal Year 2014 Earnings Call investment picks
2014/11/20
Morgan Stanley forecasts 75 billion “things” will connect to the Internet by 2020, ranging from wearable devices to appliances, transportation and automobiles, and industrial equipment.
Sign-up for Vitesse Simplifies IoT Networking with Industry’s Only Turnkey Software for Industrial Applications investment picks
Vitesse Semiconductor Corporation (Nasdaq: VTSS), a leading provider of IC solutions to advance "Ethernet Everywhere" in Carrier , Enterprise and Internet of Things ( IoT) networks , will host one-on-one meetings with investors at The Benchmark Company Micro Cap Discovery Conference at The Palmer House Hilton in Chicago on December 11, 2014.
Sign-up for Vitesse to Participate in The Benchmark Company Micro Cap Discovery Conference investment picks
2014/12/11
Executives, Economists, Industry Experts Explore World Energy Issues at 8th Annual Event NEW YORK , Dec.
Sign-up for Vitol CEO Ian Taylor at Platts Global Energy Outlook Forum: Plunging Oil Prices Part of Long-Term Market Cycle of Highs and Lows investment picks
2014/11/3
"Transition & Transformation" Themed Event to be Held December 11 in New York City NEW YORK , Nov.
Sign-up for Vitol Group's Ian Taylor to Keynote 2014 Platts Global Energy Outlook Forum investment picks
2014/11/19
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G026899-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/11/20/11G026899/Vivakor_logo-191968837290-787324512543-655670821004.jpg IRVINE, CA--(Marketwired - November 19, 2014) - Vivakor Inc. (PINKSHEETS: VIVK) announced GAAP based financial results for the quarter ended September 30, 2014.
Sign-up for Vivakor Surprises Again With Solid 3rd Quarter 2014 Financials and 6th Straight Quarter of Positive Results investment picks
2014/11/19
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G026785-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/11/19/11G026785/Logo1-829920923.jpg SUNNYVALE, CA--(Marketwired - November 19, 2014) - Viveve Medical, Inc. ("Viveve") (PINKSHEETS: VIVMF), the parent company to Viveve, Inc., a company focused on women's health, today announced that it unveiled its new website www.viveve.com .
Sign-up for Viveve Announces the Launch of Its New Website investment picks
2014/11/14
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G026389-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/11/14/11G026389/Logo1-61766060.jpg SUNNYVALE, CA--(Marketwired - November 14, 2014) - Viveve Medical, Inc. ("Viveve") (PINKSHEETS: VIVMF), the parent company to Viveve, Inc., a company focused on women's health, today reported financial results for the period ended September 30, 2014.
Sign-up for Viveve Reports Third Quarter 2014 Financial Results investment picks
2014/11/17
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G026390-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/11/14/11G026390/Logo1-1880689600.jpg SUNNYVALE, CA--(Marketwired - November 17, 2014) - Viveve Medical, Inc. ("Viveve") (PINKSHEETS: VIVMF), a company focused on women's health, today announced that Patricia Scheller, Chief Executive Officer, will present at the Canaccord Genuity, 2014 Medical Technology & Diagnostics Forum on Thursday, November 20th at 8:20am EST at the Westin Grand Central in New York, NY.
Sign-up for Viveve to Present at the Canaccord Genuity - 2014 Medical Technology & Diagnostics Forum investment picks
2014/11/27
Shareholder rights law firm Johnson & Weaver, LLP reminds investors that they have until January 20, 2015 to file a motion seeking to be appointed lead plaintiff against Vivint Solar, Inc. (NYSE:VSLR). Johnson & Weaver is the firm that filed the initial class action complaint alleging violations of federal securities laws against Vivint Solar, Inc. and certain of its officers and directors.
Sign-up for VIVINT ALERT: Johnson & Weaver, LLP Files Class Action Complaint Against Certain Officers and Directors of Vivint Solar, Inc.; Investors Encouraged to Contact the Firm investment picks
2014/9/30
LEHI, Utah , Sept.
Sign-up for Vivint Solar Announces Pricing Of Initial Public Offering investment picks
Megawatts Installed Grew 196% Year-over-Year Retained Value Grew 172% Year-over-Year Closed 91 Megawatts of Tax Equity Funding with Two New Partners LEHI, Utah , Nov.
Sign-up for Vivint Solar Announces Third Quarter 2014 Financial Results investment picks
2014/9/29
Blackstone-backed Vivint Solar will close its initial public offering midday Tuesday, and the solar installer's IPO is "multiple times oversubscribed," IPO Boutique said Monday.
Sign-up for Vivint Solar IPO expected Tuesday, deal oversubscribed investment picks
Solar Loan Operations Expert Joins Second Largest Residential Solar Integrator LEHI, Utah , Nov.
Sign-up for Vivint Solar Names Kent R. Williams As Vice President Of Asset Management investment picks
Leading U.S. Solar Installer Plans to Open More Than 20 New Offices Beginning in January 2015 LEHI, Utah , Dec.
Sign-up for Vivint Solar Plans To Continue Expansion In 2015 investment picks
By Claudia Assis, MarketWatch SAN FRANCISCO (MarketWatch) -- Rooftop solar installer Vivint Solar Inc. snapped up key Wall Street endorsements this week, with Credit Suisse and Goldman Sachs both rating the newcomer stock a buy and Citi rating it neutral.
Sign-up for Vivint Solar rakes in key buy ratings investment picks
FREDERICK, Md.
Sign-up for Vivint Solar Receives Business Leader Award In Maryland investment picks
By Claudia Assis, MarketWatch SAN FRANCISCO (MarketWatch) -- Shares of Vivint Solar Inc. rose Monday as Wall Street awaited the solar installer's first quarterly results since going public last month.
Sign-up for Vivint Solar rises ahead of first earnings investment picks
By Claudia Assis, MarketWatch SAN FRANCISCO (MarketWatch) -- Shares of Vivint Solar Inc. rallied Tuesday, but not enough to lift them above their initial public offering price a week after the residential-solar installer's IPO.
Sign-up for Vivint Solar rises; SolarCity, SunPower decline investment picks
2014/9/18
By Erin McCarthy Vivint Solar said Thursday that it plans to offer 20.6 million shares at $16 to $18 each in its initial public offering.
Sign-up for Vivint Solar sets IPO terms at 20.6 million shares investment picks
2014/11/10
Sign-up for Vivint Solar tanks 15% on wider-than-expected loss investment picks
Conference Call Scheduled for Monday, November 10 LEHI, Utah , Oct.
Sign-up for Vivint Solar to Report Third Quarter 2014 Financial Results investment picks
Vivocha Will Develop New, Secure Online Customer Engagement Tools with Bluemix ARMONK, N.Y. , Sept.
Sign-up for Vivocha Migrates from AWS to IBM Bluemix to Improve e-Commerce in the Cloud investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G022053-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/9/17/11G022053/vivus-724787991482.jpg MOUNTAIN VIEW, CA and CHESTERBROOK, PA--(Marketwired - September 18, 2014) - VIVUS, Inc. (NASDAQ: VVUS) and Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for STENDRA ® (avanafil). STENDRA is now the only FDA-approved erectile dysfunction (ED) medication indicated to be taken as early as approximately 15 minutes before sexual activity.
Sign-up for VIVUS and Auxilium Announce FDA Approval of STENDRA sNDA; STENDRA Now First and Only Oral Erectile Dysfunction Treatment Approved to Be Taken Approximately 15 Minutes Before Sexual Activity investment picks
MOUNTAIN VIEW, Calif., Oct.
Sign-up for VIVUS Announces Date of Third Quarter 2014 Update and Financial Results Conference Call investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G025569-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/11/5/11G025569/vivu0508-1319848479825.jpg MOUNTAIN VIEW, CA--(Marketwired - November 05, 2014) - VIVUS, Inc. (NASDAQ: VVUS), a biopharmaceutical company commercializing Qsymia ® (phentermine and topiramate extended-release) capsules CIV for the treatment of obesity, today reported its financial results for the third quarter ended September 30, 2014 and provided a business update.
Sign-up for VIVUS Reports Third Quarter 2014 Financial Results investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Vitesse Reports Fourth Quarter and Fiscal Year 2014 Results to VIVUS Reports Third Quarter 2014 Financial Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent